A social media listening study of patients experiences toward NAFLD (LISTEN-NAFLD)
Jeffrey V. Lazarus1,2; William Alazawi3; Ron Basuroy4; Laurent Castera5; Dmitrii Estulin6; Yiannoula Koulla7; Preethy Prasad4; Manuel Romero-Gomez8; Vincent Wai-Sun Wong9, Jörn M. Schattenberg10
Slide
Poster
Video
Thursday, 22 June 2023
POSTER
Liver fibrosis is associated with cardiovascular disease burden amongst patients with non-alcoholic steatohepatitis: the unCoVer-NASH longitudinal cohort study
Kathleen E. Corey1; Anurag Mehta2; Kamal Kant Mangla3; Abhishek Shankar Chandramouli4; Ahsan Shoeb Patel3; Sharat Varma3; Elisabetta Bugianesi5
Slide
Poster
Video
POSTER
Prevalence of, and effect of semaglutide on, features of non-alcoholic steatohepatitis using SomaSignal tests in patients with obesity with/without type 2 diabetes, and correlation of SomaSignal tests with histology in patients with non-alcoholic steatohepatitis: analysis of data from three randomized trials
Jörn M. Schattenberg1; Henning Grønbæk2; Iris Kliers3; Steen Ladelund3; Michelle T. Long3; Sune Boris Nygård3; Arun J. Sanyal4; Melanie Davies5,6
Slide
Poster
Video
POSTER
Treatment monitoring with the Agile 3+ score in patients with non-alcoholic steatohepatitis: analysis of data from a randomised placebo-controlled trial of semaglutide